Dolasetron
Showing 1 - 19 of 19
Chemo-induced Nausea and Vomiting Trial in Worldwide (NEPA (300mg netupitant/0.5mg palonosetron), Granisetron, 2 mg (oral) or 1
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- NEPA (300mg netupitant/0.5mg palonosetron)
- +2 more
-
Prague, Czechia
- +12 more
Nov 8, 2022
Pain, Postoperative, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip Trial in Changchun (37.5mg Pregabalin +
Completed
- Pain, Postoperative
- +2 more
- 37.5mg Pregabalin + 75mg Pregabalin
- 75mg Pregabalin
-
Changchun, ChinaThe First Hospital of Jilin University
Oct 23, 2022
Postoperative Nausea and Vomiting Trial in Nashville (procedure, device, drug)
Completed
- Postoperative Nausea and Vomiting
- Automated recommendation at the start of the case
- +37 more
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 5, 2019
Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Feb 10, 2022
Glioblastoma Multiforme Trial in United States (Bevacizumab and Temozolomide)
Completed
- Glioblastoma Multiforme
- Bevacizumab and Temozolomide
-
Chicago, Illinois
- +4 more
Mar 5, 2021
Cesarean Section Trial in Xuzhou (dexmedetomidine group, control group)
Completed
- Cesarean Section
- dexmedetomidine group
- control group
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 2, 2019
Nausea and Vomiting, Chemo-Induced Trial in Evansville (casopitant, dolasetron, granisetron)
Completed
- Nausea and Vomiting, Chemotherapy-Induced
- casopitant
- +3 more
-
Evansville, IndianaGSK Investigational Site
Aug 2, 2017
Malignant Digestive System Tumor, Nausea and Vomiting Trial in Los Angeles (Aprepitant, Dexamethasone, Dolasetron Mesylate)
Terminated
- Malignant Digestive System Neoplasm
- Nausea and Vomiting
- Aprepitant
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Mar 24, 2017
Nausea and Vomiting, Postoperative Trial in Rio de Janeiro (Palonosetron, Fosaprepitant)
Unknown status
- Nausea and Vomiting, Postoperative
-
Rio de Janeiro, BrazilHospital Federal de Bonsucesso
Mar 10, 2019
Pancreatic Cancer Trial in Kansas City (Intravenous Vitamin C, Gemcitabine)
Completed
- Pancreatic Cancer
- Intravenous Vitamin C
- Gemcitabine
-
Kansas City, KansasUniversity of Kansas Medical Center
Jun 16, 2018
Non Small Cell Lung Cancer, Lung Cancer Trial in Lebanon (ABT-751 and Carboplatin)
Terminated
- Non Small Cell Lung Cancer
- Lung Cancer
- ABT-751 and Carboplatin
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Oct 8, 2018
Vitreoretinal Surgeries, Postoperative Nausea and Vomiting, Postoperative Pain Trial in Sosnowiec (Metamizol, Acetaminophen, 0,5
Completed
- Vitreoretinal Surgeries
- +2 more
- Metamizol
- +3 more
-
Sosnowiec, Silesia, PolandMedical University of Silesia
Jan 18, 2018
Postoperative Nausea and Vomiting Trial in Boston (Caffeine)
Completed
- Postoperative Nausea and Vomiting
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 3, 2017
Nausea and Vomiting, Solid Tumor Trial in Hackensack, Rochester (dolasetron mesylate, granisetron HCl, ondansetron)
Completed
- Nausea and Vomiting
- Unspecified Adult Solid Tumor, Protocol Specific
- dolasetron mesylate
- +4 more
-
Hackensack, New Jersey
- +1 more
Oct 13, 2015
Nausea and Vomiting, Solid Tumor Trial in United States (dolasetron mesylate, granisetron HCl, ondansetron)
Completed
- Nausea and Vomiting
- Unspecified Adult Solid Tumor, Protocol Specific
- dolasetron mesylate
- +4 more
-
Mobile, Alabama
- +14 more
Oct 13, 2015
Fibromyalgia Trial in Limoges (Dolasetron, Placebo)
Completed
- Fibromyalgia
- Dolasetron
- Placebo
-
Limoges, FranceService de Rhumatologie, CHu de Limoges
Jan 9, 2009